Metastatic Bladder Cancer
Also known as: Bladder Cancer, Metastatic
Drug | Drug Name | Drug Description |
---|---|---|
DB01248 | Docetaxel | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
DB01229 | Paclitaxel | A taxoid chemotherapeutic agent used as first-line and subsequent therapy for the treatment of advanced carcinoma of the ovary, and other various cancers including breast and lung cancer. |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11595 | Atezolizumab | 1 | Recruiting | 1 |
DB09035 | Nivolumab | 1 | Completed | 1 |
DB16409 | Tiragolumab | 1 | Recruiting | 1 |
DB11595 | Atezolizumab | 1 / 2 | Active Not Recruiting | 1 |
DB11945 | Avelumab | 1 / 2 | Terminated | 1 |
DB00515 | Cisplatin | 1 / 2 | Active Not Recruiting | 1 |
DB14873 | Enadenotucirev | 1 / 2 | Completed | 1 |
DB16168 | Fluorocyclopentenylcytosine | 1 / 2 | Completed | 1 |
DB00441 | Gemcitabine | 1 / 2 | Active Not Recruiting | 1 |
DB06094 | Apatorsen | 2 | Completed | 1 |
DB11595 | Atezolizumab | 2 | Recruiting | 1 |
DB11945 | Avelumab | 2 | Terminated | 1 |
DB00958 | Carboplatin | 2 | Completed | 1 |
DB00958 | Carboplatin | 2 | Terminated | 1 |
DB00515 | Cisplatin | 2 | Completed | 1 |
DB00515 | Cisplatin | 2 | Terminated | 1 |
DB11714 | Durvalumab | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Terminated | 1 |
DB11771 | Tremelimumab | 2 | Completed | 1 |
DB15442 | Trilaciclib | 2 | Terminated | 1 |